DaVita (STU:TRL) Debt-to-Equity : 31.54 (As of Sep. 2024)

View and export this data going back to 1995. Start your Free Trial

What is DaVita Debt-to-Equity?

DaVita's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €631 Mil. DaVita's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €10,359 Mil. DaVita's Total Stockholders Equity for the quarter that ended in Sep. 2024 was €348 Mil. DaVita's debt to equity for the quarter that ended in Sep. 2024 was 31.54.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for DaVita's Debt-to-Equity or its related term are showing as below:

STU:TRL' s Debt-to-Equity Range Over the Past 10 Years
Min: 1.63 Med: 5.03 Max: 31.54
Current: 31.54

During the past 13 years, the highest Debt-to-Equity Ratio of DaVita was 31.54. The lowest was 1.63. And the median was 5.03.

STU:TRL's Debt-to-Equity is ranked worse than
99.82% of 551 companies
in the Healthcare Providers & Services industry
Industry Median: 0.47 vs STU:TRL: 31.54

DaVita Debt-to-Equity Historical Data

The historical data trend for DaVita's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Debt-to-Equity Chart

DaVita Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

5.24

8.09

15.85

16.60

10.53

DaVita Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial															9.28	10.53	12.79	18.45	31.54

Competitive Comparison of DaVita's Debt-to-Equity

For the Medical Care Facilities subindustry, DaVita's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DaVita's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where DaVita's Debt-to-Equity falls into.

DaVita Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

DaVita's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(474.729	+	9719.029)	/	968.441
	=	10.53

DaVita's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(631.416	+	10359.217)	/	348.43
	=	31.54

DaVita (STU:TRL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

DaVita Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of DaVita's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

DaVita Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (STU:TRL) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

DVA:USA 0I7E:UK TRL:Germany DVAI34:Brazil

Address

2000 16th Street, Denver, CO, USA, 80202

Website

https://www.davita.com

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.

DaVita Headlines

No Headlines